Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions.

scientific article published on 29 October 2004

Pseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1152/AJPLUNG.00322.2004
P698PubMed publication ID15516485
P5875ResearchGate publication ID8204848

P50authorRuud VeldhuizenQ60730440
P2093author name stringJo Rae Wright
Brett A Thibodeaux
Richard J O'Callaghan
Jaret L Malloy
P2860cites workExpression and localization of lung surfactant protein A in human tissuesQ28207683
Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infectionQ28284528
Protease IV, a unique extracellular protease and virulence factor from Pseudomonas aeruginosaQ28492810
Degradation of pulmonary surfactant protein D by Pseudomonas aeruginosa elastase abrogates innate immune functionQ28493115
Surfactant Proteins A and D and Pulmonary Host DefenseQ30049091
Pseudomonas aeruginosa lipopolysaccharides and pathogenesisQ30469943
Characterization of an endoprotease (PrpL) encoded by a PvdS-regulated gene in Pseudomonas aeruginosaQ34008850
Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunistQ34019954
Collections and ficolins: humoral lectins of the innate immune defenseQ34169976
Pulsating bubble technique for evaluating pulmonary surfactantQ36573848
Regulation of pulmonary surfactant secretion and clearanceQ37739420
Secretion of extracellular proteins by Pseudomonas aeruginosaQ37821408
Human surfactant protein B: structure, function, regulation, and genetic diseaseQ40370763
Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virusQ40579448
Proteolytic inactivation of dog lung surfactant-associated proteins by neutrophil elastaseQ41322766
Surface-area cycling of different surfactant preparations: SP-A and SP-B are essential for large-aggregate integrityQ42834889
Macrophage and type II cell catabolism of SP-A and saturated phosphatidylcholine in mouse lungsQ43606169
Pseudomonas aeruginosa elastase degrades surfactant proteins A and D.Q44374316
Neutrophil serine proteinases inactivate surfactant protein D by cleaving within a conserved subregion of the carbohydrate recognition domainQ44840275
Pulmonary surfactant: functions and molecular composition.Q46027561
Surface activity of rabbit pulmonary surfactant subfractions at different concentrations in a captive bubbleQ46063626
Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection.Q51659562
P433issue2
P921main subjectPseudomonas aeruginosaQ31856
P304page(s)L409-18
P577publication date2004-10-29
P1433published inAmerican Journal of Physiology - Lung Cellular and Molecular PhysiologyQ4352992
P1476titlePseudomonas aeruginosa protease IV degrades surfactant proteins and inhibits surfactant host defense and biophysical functions
P478volume288

Reverse relations

cites work (P2860)
Q39384774A Pseudomonas aeruginosa-secreted protease modulates host intrinsic immune responses, but how?
Q34695043A Vibrio cholerae protease needed for killing of Caenorhabditis elegans has a role in protection from natural predator grazing
Q45856453Adenoviral gene transfer of a mutant surfactant enzyme ameliorates pseudomonas-induced lung injury.
Q54970130Airway Epithelium Dysfunction in Cystic Fibrosis and COPD.
Q21131225An Insight into the Diverse Roles of Surfactant Proteins, SP-A and SP-D in Innate and Adaptive Immunity
Q37418480An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease
Q37814698Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD).
Q42029143Changes in Galleria mellonella lysozyme level and activity during Pseudomonas aeruginosa infection.
Q44044915Chronic Pseudomonas aeruginosa infection reduces surfactant levels by inhibiting its biosynthesis.
Q41891809Clearance of Pseudomonas aeruginosa from a healthy ocular surface involves surfactant protein D and is compromised by bacterial elastase in a murine null-infection model.
Q35687472Evidence for Autoinduction and Quorum Sensing in White Band Disease-Causing Microbes on Acropora cervicornis
Q34871061Evolution of Pseudomonas aeruginosa virulence as a result of phage predation.
Q39421726Evolution of surfactant protein-D levels in children with ventilator-associated pneumonia
Q38136000Failure of respiratory defenses in the pathogenesis of bacterial pneumonia of cattle.
Q30414550Genes required for and effects of alginate overproduction induced by growth of Pseudomonas aeruginosa on Pseudomonas isolation agar supplemented with ammonium metavanadate
Q41886610Human pre-elafin inhibits a Pseudomonas aeruginosa-secreted peptidase and prevents its proliferation in complex media
Q37837985IgA modulates respiratory dysfunction as a sequela to pulmonary chlamydial infection as neonates
Q36567361Infectious keratitis: secreted bacterial proteins that mediate corneal damage
Q35566398Innate immune responses to Pseudomonas aeruginosa infection.
Q98882243Interactions of particulate matter and pulmonary surfactant: Implications for human health
Q36895297Life at the front: dissecting bacterial-host interactions at the ocular surface.
Q92026612Lung infection caused by Pseudomonas aeruginosa in a CD26/DPP4 deficient F344 rat model
Q60922656Mechanism of Pseudomonas aeruginosa Small Protease (PASP), a Corneal Virulence Factor
Q27001070Pouring salt on a wound: Pseudomonas aeruginosa virulence factors alter Na+ and Cl- flux in the lung
Q40251529Proapoptotic effects of P. aeruginosa involve inhibition of surfactant phosphatidylcholine synthesis
Q24607872Properties of PASP: a Pseudomonas protease capable of mediating corneal erosions
Q38021378Proteases, cystic fibrosis and the epithelial sodium channel (ENaC).
Q35784995Protective Role of Surfactant Protein D in Ocular Staphylococcus aureus Infection
Q92825829Pseudomonas aeruginosa Keratitis: Protease IV and PASP as Corneal Virulence Mediators
Q55296887Pseudomonas aeruginosa Protease IV Exacerbates Pneumococcal Pneumonia and Systemic Disease.
Q40477924Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense.
Q36784102Pseudomonas aeruginosa small protease (PASP), a keratitis virulence factor
Q33405478Pseudomonas aeruginosa vesicles associate with and are internalized by human lung epithelial cells
Q38101888Pseudomonas aeruginosa: new insights into pathogenesis and host defenses
Q33890598Recombinant expression and functional analysis of proteases from Streptococcus pneumoniae, Bacillus anthracis, and Yersinia pestis
Q24815739Sequential analysis of surfactant, lung function and inflammation in cystic fibrosis patients.
Q33736033Single step concomitant concentration, purification and characterization of two families of lipopeptides of marine origin.
Q55269439Surfactant Protein D in Respiratory and Non-Respiratory Diseases.
Q28395117Surfactant and its role in the pathobiology of pulmonary infection
Q36163103The Pseudomonas aeruginosa PhoP-PhoQ two-component regulatory system is induced upon interaction with epithelial cells and controls cytotoxicity and inflammation
Q34594227The Pseudomonas aeruginosa flagellum confers resistance to pulmonary surfactant protein-A by impacting the production of exoproteases through quorum-sensing
Q26865690The Role of Surfactant in Lung Disease and Host Defense against Pulmonary Infections
Q33924226The effect of matrix metalloproteinase-3 deficiency on pulmonary surfactant in a mouse model of acute lung injury.
Q33288960The flagellum of Pseudomonas aeruginosa is required for resistance to clearance by surfactant protein A.
Q37293867Therapeutic use of surfactant components in allergic asthma

Search more.